Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration

• US 8,918,191 B2
• Filed: 12/07/2011
• Issued: 12/23/2014
• Est. Priority Date: 12/07/2011
• Status: Active Grant

• Current Assignee: LivaNova USA, Inc. (LivaNova Plc)
• Original Assignee: Cyberonics, Inc
• Inventors: Libbus, Imad, Amurthur, Badri, KenKnight, Bruce H.
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): CAREY, MICHAEL JAMES
• Application Number:
  US13/314,135
• Publication Number:
  US 20130158617A1
• Time in Patent Office: 1,112 Days
• Field of Search: 607/17, 607/40, 607/116, 607/118
• US Class Current: 607/118
• CPC Class Codes: A61N 1/0556 Cuff electrodes
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36139 with automatic adjustment
• CPC Class Codes: A61N 1/36175 Pulse width or duty cycle

Abstract

An implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration is provided. A stimulation therapy lead includes helical electrodes configured to conform to an outer diameter of a cervical vagus nerve sheath, and a set of connector pins electrically connected to the helical electrodes. A neurostimulator includes an electrical receptacle into which the connector pins are securely and electrically coupled. The neurostimulator includes a pulse generator configured to therapeutically stimulate the vagus nerve through the helical electrodes in alternating cycles of stimuli application and stimuli inhibition that are tuned to both efferently activate the heart'"'"'s intrinsic nervous system and afferently activate the patient'"'"'s central reflexes by triggering bi-directional action potentials. The neurostimulator includes an integrated leadless heart rate sensor configured to sense heart rate and alter the triggering in response to the sensed heart rate falling outside a predetermined range.

Claims

1. A vagus nerve neurostimulator for treating chronic cardiac dysfunction with bounded titration, comprising:

a pulse generator, wherein the pulse generator generates a pulsed electrical signal comprising;

a signal ON time;

a signal OFF time;

an output current;

a signal frequency of approximately 10 Hz;

a pulse width; and

a duty cycle defined by dividing the signal ON time by the sum of the signal ON time and signal OFF time;

a therapy lead;

an electrode communicatively coupled to the pulse generator via the therapy lead, wherein the electrical signal is applied to a vagus nerve via the electrode to propagate action potentials in both afferent and efferent directions along the vagus nerve; and

a leadless heart rate sensor configured to sense and record a patient'"'"'s heart rate in response to the pulsed electrical signal, wherein the pulse generator is configured to alter the pulsed electrical signal in response to the sensed heart rate falling outside of a stored predetermined range of acceptable heart rates.

2. The vagus nerve neurostimulator according to claim 1, wherein the pulsed electrical signal further comprises a signal ramp-up time.

3. The vagus nerve neurostimulator according to claim 1, wherein the pulsed electrical signal further comprises a signal ramp-down time.

4. The vagus nerve neurostimulator according to claim 1, wherein the duty cycle comprises a value in a range of 5% to 20%.

5. The vagus nerve neurostimulator according to claim 1, wherein application of the electrical signal to the vagus nerve further induces heart rate variability during the signal ON time.

6. The vagus nerve neurostimulator according to claim 1, wherein the pulsed electrical signal further comprises a ramp-up time and a ramp-down time;

and

application of the electrical signal to the vagus nerve further induces heart rate variability during the ramp-up time, the signal ON time, and the ramp-down time.

7. The vagus nerve neurostimulator according to claim 1, wherein the vagus nerve neurostimulator is configured to alter the pulsed electrical signal in response to the sensed heart rate falling outside of a stored predetermined range of acceptable heart rates by suspending application of the pulsed electrical signal to the vagus nerve for a fixed period of time in response to the sensed heart falling below a stored lower bound.

8. The vagus nerve neurostimulator according to claim 1, wherein the vagus nerve neurostimulator is configured to alter the pulsed electrical signal in response to the sensed heart rate falling outside of a stored predetermined range of acceptable heart rates by gradually down titrating the pulsed electrical signal in response to the sensed heart rate falling below a stored lower bound.

9. The vagus nerve neurostimulator according to claim 1, wherein the vagus nerve neurostimulator is configured to alter the pulsed electrical signal in response to the sensed heart rate falling outside of a stored predetermined range of acceptable heart rates by gradually up titrating the electrical signal in response to the sensed heart rate rising above a stored upper bound.

10. The vagus nerve neurostimulator according to claim 1, wherein the therapy lead comprises a cervical vagus nerve stimulation therapy lead electrically coupled to the pulse generator and terminated by a pair of helical electrodes through which the pulsed electrical signal is delivered to the patient'"'"'s cervical vagus nerve.

11. The vagus nerve neurostimulator according to claim 10, further comprising an electrical receptacle comprised on an outer surface of the neurostimulator, wherein said cervical vagus nerve stimulation therapy lead comprises a connector pin electrically coupled to the pulse generator and an insulated electrical lead body electrically coupled to the helical electrodes.

12. The vagus nerve neurostimulator according to claim 1, further comprising a recordable memory storing the predetermined range of acceptable heart rates, wherein said predetermined range of acceptable heart rates is indicative of at least one of bradycardia and asystole.

13. The vagus nerve neurostimulator according to claim 1, wherein a lower bound of said predetermined range of acceptable heart rates is expressed as at least one of a ratio, a percentile, a function, and discrete independent values with respect to the sensed heart rate.

20. The vagus nerve neurostimulator according to claim 1, wherein the therapy lead comprises a cervical vagus nerve stimulation therapy lead electrically coupled to the pulse generator and terminated by a pair of helical electrodes through which the pulsed electrical signal is delivered to the patient'"'"'s cervical vagus nerve.

21. The vagus nerve neurostimulator according to claim 20, further comprising an electrical receptacle comprised on an outer surface of the neurostimulator, wherein said cervical vagus nerve stimulation therapy lead comprises a connector pin electrically coupled to the pulse generator and an insulated electrical lead body electrically coupled to the helical electrodes.

14. A vagus nerve neurostimulator for treating chronic cardiac dysfunction with bounded titration, comprising:

a pulse generator, wherein the pulse generator generates a pulsed electrical signal comprising;

a signal ramp-up time;

a signal ramp-down time;

a signal ON time;

a signal OFF time;

an output current;

a signal frequency of approximately 10 Hz;

a pulse width; and

a duty cycle defined by dividing the signal ON time by the sum of the signal ON time and signal OFF time;

a therapy lead;

an electrode communicatively coupled to the pulse generator via the therapy lead, wherein the electrical signal is applied to a vagus nerve via the electrode to propagate action potentials in both afferent and efferent directions along the vagus nerve; and

a leadless heart rate sensor configured to sense and record a patient'"'"'s heart rate in response to the pulsed electrical signal, wherein the pulse generator is configured to alter the pulsed electrical signal in response to the sensed heart rate falling outside of a stored predetermined range of acceptable heart rates.

15. The vagus nerve neurostimulator according to claim 14, wherein application of the electrical signal to the vagus nerve further induces heart rate variability during the ramp-up time, the signal ON time, and the ramp-down time.

16. The vagus nerve neurostimulator according to claim 14, wherein the signal ramp-up time is two seconds.

17. The vagus nerve neurostimulator according to claim 14, wherein the signal ramp-down time is two seconds.

18. The vagus nerve neurostimulator according to claim 14, wherein the output current, the signal frequency or the pulse width of the pulsed electrical signal is modified during the ramp-up time.

19. The vagus nerve neurostimulator according to claim 14, wherein the output current, the signal frequency or the pulse width of the pulsed electrical signal is modified during the ramp-down time.

22. The vagus nerve neurostimulator according to claim 14, further comprising a recordable memory storing the predetermined range of acceptable heart rates, wherein said predetermined range of acceptable heart rates is indicative of at least one of bradycardia and asystole.

23. The vagus nerve neurostimulator according to claim 14, wherein a lower bound of said predetermined range of acceptable heart rates is expressed as at least one of a ratio, a percentile, a function, and discrete independent values with respect to the sensed heart rate.

30. The vagus nerve neurostimulator according to claim 14, wherein:

during the signal ON time, the output current of the pulsed electrical signal comprises a full output current;

during the signal OFF time, the output current of the pulsed electrical signal comprises an inhibited output current;

during the signal ramp-up time, the output current of the pulsed electrical signal increases from the inhibited output current to the full output current; and

during the signal ramp-down time, the output current of the pulsed electrical signal decreases from the full output current to the inhibited output current.

24. A vagus nerve neurostimulator for treating chronic cardiac dysfunction with bounded titration, comprising:

a pulse generator, wherein the pulse generator generates a pulsed electrical signal comprising;

a signal ON time;

a signal OFF time;

an output current;

a signal frequency of approximately 10 Hz;

a pulse width; and

a duty cycle defined by dividing the signal ON time by the sum of the signal ON time and signal OFF time;

a therapy lead;

an electrode communicatively coupled to the pulse generator via the therapy lead, wherein the electrical signal is applied to a vagus nerve via the electrode to;

propagate action potentials in both afferent and efferent directions along the vagus nerve; and

induce heart rate variability during the signal ON time; and

a leadless heart rate sensor configured to sense and record a patient'"'"'s heart rate in response to the pulsed electrical signal, wherein the pulse generator is configured to alter the pulsed electrical signal in response to the sensed heart rate falling outside of a stored predetermined range of acceptable heart rates.

25. The vagus nerve neurostimulator according to claim 24, wherein the pulsed electrical signal further comprises a signal ramp-up time.

26. The vagus nerve neurostimulator according to claim 24, wherein the pulsed electrical signal further comprises a signal ramp-down time.

27. The vagus nerve neurostimulator according to claim 24, wherein the duty cycle comprises a value in a range of 5% to 20%.

28. The vagus nerve neurostimulator according to claim 24, further comprising a recordable memory storing the predetermined range of acceptable heart rates, wherein said predetermined range of acceptable heart rates is indicative of at least one of bradycardia and asystole.

29. The vagus nerve neurostimulator according to claim 24, wherein a lower bound of said predetermined range of acceptable heart rates is expressed as at least one of a ratio, a percentile, a function, and discrete independent values with respect to the sensed heart rate.